IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q1 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,061,000 | +12.0% | 54,530 | -4.2% | 0.01% | 0.0% |
| Q4 2017 | $947,000 | -18.2% | 56,895 | -0.3% | 0.01% | -28.6% |
| Q3 2017 | $1,158,000 | +30.1% | 57,071 | +3.2% | 0.01% | +40.0% |
| Q2 2017 | $890,000 | +143.2% | 55,286 | +91.2% | 0.01% | +66.7% |
| Q1 2017 | $366,000 | +57.1% | 28,920 | +64.6% | 0.00% | +50.0% |
| Q4 2016 | $233,000 | -33.4% | 17,570 | +18.9% | 0.00% | -33.3% |
| Q3 2016 | $350,000 | -0.3% | 14,776 | +21.4% | 0.00% | 0.0% |
| Q2 2016 | $351,000 | -22.2% | 12,168 | -13.5% | 0.00% | -25.0% |
| Q1 2016 | $451,000 | -15.9% | 14,071 | +12.3% | 0.00% | -20.0% |
| Q4 2015 | $536,000 | +44.1% | 12,534 | +18.6% | 0.01% | +25.0% |
| Q3 2015 | $372,000 | -22.8% | 10,571 | +0.8% | 0.00% | -20.0% |
| Q2 2015 | $482,000 | +5.7% | 10,489 | +7.7% | 0.01% | 0.0% |
| Q1 2015 | $456,000 | +92.4% | 9,738 | +29.9% | 0.01% | +66.7% |
| Q4 2014 | $237,000 | – | 7,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
| Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
| Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
| Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
| Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
| Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
| SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
| Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |